Insider Buy/Sell Details for the Biotechnology Industry — August 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (582)
Liquidia Corp (LQDA)
Saggar Rajeev — Chief Medical Officer
Shares
50,000
Price
$74.06
Total Value
$3.70M
Shares Held After
142,265
% of Holdings
26.0%
Camp4 Therapeutics Corp (CAMP)
Tardiff Daniel — Chief Scientific Officer
Shares
1,738
Price
$4.76
Total Value
$8.27K
Shares Held After
0
% of Holdings
100.0%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
3,200
Price
$107.77
Total Value
$344.85K
Shares Held After
767,780
% of Holdings
0.4%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,600
Price
$107.22
Total Value
$1.03M
Shares Held After
770,980
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
7,200
Price
$106.36
Total Value
$765.78K
Shares Held After
780,580
% of Holdings
0.9%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
30,918
Price
$1.65
Total Value
$50.89K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
31,000
Price
$1.65
Total Value
$51.03K
Shares Held After
48,750
% of Holdings
38.9%
Fortrea Holdings Inc. (FTRE)
Morais Mark A. — Chief Operating Officer
Shares
4,892
Price
$18.19
Total Value
$88.99K
Shares Held After
77,786
% of Holdings
5.9%
Dianthus Therapeutics, Inc. /DE/ (DNTH)
Read Simon — Director
Shares
2,778
Price
$117.55
Total Value
$326.55K
Shares Held After
0
% of Holdings
100.0%
Mirum Pharmaceuticals, Inc. (MIRM)
Howe Jolanda — SVP, GLOBAL CONTROLLER
Shares
40,000
Price
$100.00
Total Value
$4.00M
Shares Held After
1,274
% of Holdings
96.9%
Artiva Biotherapeutics, Inc. (ARTV)
Banerjee Subhashis — Chief Medical Officer
Shares
429
Price
$12.00
Total Value
$5.15K
Shares Held After
144,963
% of Holdings
0.3%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
204
Price
$25.14
Total Value
$5.13K
Shares Held After
2,180,518
% of Holdings
0.0%
Adaptive Biotechnologies Corp (ADPT)
ROBINS CHAD M — Director
Shares
278,472
Price
$24.48
Total Value
$6.82M
Shares Held After
2,180,722
% of Holdings
11.3%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
9,400
Price
$104.87
Total Value
$985.82K
Shares Held After
767,780
% of Holdings
1.2%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
4,897
Price
$104.11
Total Value
$509.83K
Shares Held After
777,180
% of Holdings
0.6%
HALOZYME THERAPEUTICS, INC. (HALO)
Torley Helen — Director
Shares
5,703
Price
$103.08
Total Value
$587.88K
Shares Held After
782,077
% of Holdings
0.7%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
34,987
Price
$1.59
Total Value
$55.49K
Shares Held After
0
% of Holdings
100.0%
Neumora Therapeutics, Inc. (NMRA)
Aurora Daljit Singh — Chief Operating and Development Officer
Shares
34,162
Price
$1.58
Total Value
$54.14K
Shares Held After
48,750
% of Holdings
41.2%
Seer, Inc. (SEER)
Horn David R. — PRESIDENT&CFO
Shares
7,309
Price
$2.03
Total Value
$14.81K
Shares Held After
486,650
% of Holdings
1.5%
Lexeo Therapeutics, Inc. (LXEO)
Otero Jose Manuel — Chief Operating Officer
Shares
1,304
Price
$4.96
Total Value
$6.46K
Shares Held After
136,178
% of Holdings
0.9%
Lexeo Therapeutics, Inc. (LXEO)
Townsend Richard Nolan — Director
Shares
3,345
Price
$4.95
Total Value
$16.56K
Shares Held After
374,472
% of Holdings
0.9%
Lexeo Therapeutics, Inc. (LXEO)
Tamayo Louis Edward — Chief Financial Officer
Shares
4,117
Price
$4.91
Total Value
$20.20K
Shares Held After
92,907
% of Holdings
4.2%
Avalo Therapeutics, Inc. (AVTX)
Sullivan Christopher Ryan — Chief Financial Officer
Shares
31,031
Price
$20.05
Total Value
$622.32K
Shares Held After
39,900
% of Holdings
43.7%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
900
Price
$63.86
Total Value
$57.47K
Shares Held After
61,500
% of Holdings
1.4%
Travere Therapeutics, Inc. (TVTX)
LYONS GARY A — Director
Shares
4,100
Price
$63.27
Total Value
$259.39K
Shares Held After
62,400
% of Holdings
6.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
441
Price
$518.65
Total Value
$228.72K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,630
Price
$518.19
Total Value
$844.64K
Shares Held After
324,884
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
873
Price
$517.09
Total Value
$451.42K
Shares Held After
326,514
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,880
Price
$516.04
Total Value
$970.16K
Shares Held After
327,387
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
2,333
Price
$514.99
Total Value
$1.20M
Shares Held After
329,267
% of Holdings
0.7%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,264
Price
$514.18
Total Value
$649.92K
Shares Held After
331,600
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
439
Price
$513.06
Total Value
$225.23K
Shares Held After
332,864
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
170
Price
$511.59
Total Value
$86.97K
Shares Held After
333,303
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
231
Price
$510.47
Total Value
$117.92K
Shares Held After
333,473
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
239
Price
$509.48
Total Value
$121.77K
Shares Held After
333,704
% of Holdings
0.1%
Royalty Pharma plc (RPRX)
Hite Christopher — EVP&Chairman, Partnering
Shares
100,000
Price
$59.97
Total Value
$6.00M
Shares Held After
370,401
% of Holdings
21.3%
MeiraGTx Holdings plc (MGTX)
Forbes Alexandria — Director
Shares
62,000
Price
$13.86
Total Value
$859.32K
Shares Held After
1,325,695
% of Holdings
4.5%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
31,801
Price
$37.18
Total Value
$1.18M
Shares Held After
18,630,739
% of Holdings
0.2%
Roivant Sciences Ltd. (ROIV)
Sukhatme Mayukh — Director
Shares
105,141
Price
$36.59
Total Value
$3.85M
Shares Held After
18,630,739
% of Holdings
0.6%
Invivyd, Inc. (IVVD)
Andersen Jill — Chief Legal Officer, Secretary
Shares
30,706
Price
$0.84
Total Value
$25.88K
Shares Held After
283,774
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
145
Price
$32.47
Total Value
$4.71K
Shares Held After
21,225
% of Holdings
0.7%
Stoke Therapeutics, Inc. (STOK)
Allan Jonathan — GENERAL COUNSEL&CORP SEC
Shares
2,716
Price
$32.01
Total Value
$86.93K
Shares Held After
21,370
% of Holdings
11.3%
Invivyd, Inc. (IVVD)
Duke William E. — Chief Financial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Invivyd, Inc. (IVVD)
Lee Timothy Edward — Chief Commercial Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
178,937
% of Holdings
9.3%
Invivyd, Inc. (IVVD)
Allen Robert D. III — Chief Scientific Officer
Shares
17,043
Price
$0.84
Total Value
$14.37K
Shares Held After
178,765
% of Holdings
8.7%
Invivyd, Inc. (IVVD)
Green Julie — Chief Human Resources Officer
Shares
18,425
Price
$0.84
Total Value
$15.53K
Shares Held After
168,937
% of Holdings
9.8%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
242
Price
$32.47
Total Value
$7.86K
Shares Held After
25,655
% of Holdings
0.9%
Stoke Therapeutics, Inc. (STOK)
Ticho Barry — CHIEF MEDICAL OFFICER
Shares
4,525
Price
$32.01
Total Value
$144.83K
Shares Held After
25,897
% of Holdings
14.9%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
637
Price
$32.47
Total Value
$20.68K
Shares Held After
124,557
% of Holdings
0.5%
Stoke Therapeutics, Inc. (STOK)
Kaye Edward M. MD — Director
Shares
11,930
Price
$32.01
Total Value
$381.85K
Shares Held After
125,194
% of Holdings
8.7%
Showing 1–50 of 582 transactions (page 1 of 12)